Diabetes mellitus statistics on prevalence and mortality: facts and fallacies

Abstract

Diabetes mellitus is one of the most important public health challenges of the twenty-first century. Until the past decade, it has been seriously underrated as a global health threat. Major gaps exist in efforts to comprehend the burden nationally and globally, especially in developing nations, due to a lack of accurate data for monitoring and surveillance. Early attempts to obtain accurate data, discussed in this article, seem to have been cast aside so, at present, these needs remain unmet. Existing international efforts to assemble information fall far short of requirements. Current estimates are imprecise, only providing a rough picture, and probably underestimate the disease burden. The methodologies that are currently used, and that are discussed in this Perspectives article, are inadequate for providing a complete and accurate assessment of the prevalence of diabetes mellitus. International consensus on uniform standards and criteria for reporting national data on diabetes mellitus prevalence as well as for common complications of diabetes mellitus and mortality need to be developed.

Urinary and Blood MicroRNA-126 and -770 are Potential Noninvasive Biomarker Candidates for Diabetic Nephropathy: a Meta-Analysis

“…By 2040, diabetes mellitus incidence is predicted to rise to 642 million (uncertainty interval: 521-829 million) [2]. The 2015 mortality from diabetes mellitus was 5.0 million deaths; that number is predicted to increase by 34% in 2030 [3]. These tremendous increases in diabetes mellitus incidence (now affecting 1 of 11 persons) are believed to be due to now-endemic obesity and sedentary lifestyles [1].…”

Nogo-B Promotes Angiogenesis in Proliferative Diabetic Retinopathy via VEGF/PI3K/Akt Pathway in an Autocrine Manner

“…Diabetes mellitus is one of the most common metabolic diseases and is associated with long-term damage of various organs [1, 2]. Despite the well-developed diagnosis and medical care, the global prevalence of diabetes will increase to 366 million by 2030 estimated by the World Health Organization [3].…”

Obesity and the Link to Chronic Disease Development

“…The prevalence of type 2 diabetes (T2D) has more than doubled worldwide in the past 20 years [10], and 80% of people with T2D are also obese [11]. Obesity causes adipocytes to be enlarged, which leads to the dysregulation of adipokine secretion [12].…”